David C. Youngentob
Director @Willamette Valley Capital
Signup · Get unlimited contacts
WORK HISTORY
Director @Willamette Valley Capital
Albany, OR, US
Leadership of deal team operations and partnering with Fund Manager and Venture Principals to make well justified investments in world-class venture startups. High level of partnership with our group\'s associates, analysts, and interns to activate, monitor, and manage WVC\'s deal flow pipeline across sourcing, screening, diligence, and investment recommendations. I am a success when I help our team find and create dialogue with inspiring entrepreneurs telling a compelling business story, particularly where WVC can provide capital and coaching to enable the venture\'s next steps.
EDUCATION
University of Oregon Lundquist College of Business
Master of Business Administration (MBA), Finance
State University of New York College of Environmental Science and Forestry
Bachelor of Science (BS), Biotechnology
University of Oregon
Master of Science (MS), Molecular Biology
SKILLS
ABOUT DAVID C. YOUNGENTOB
Manager in Corporate Business Development and Innovation M&A team at NAGRA Kudelski Group. Sourcing, screening, and enabling the validation and advancement of early stage initiatives to new product / Go-to-market launches, and corporate deals across our Digital TV, SKIDATA, Cybersecurity, and IoT business segments. High-level of partnership and work product collaboration with EVPs, VPs, and Sr leadership across all business divisions.Director with Willamette Valley Capital, a seed stage venture fund. Over 20 transactions and $3M+ of funds directly deployed in syndicated deals with over $50M+ coinvested. Expert abilities in valuation and exit modeling, and deal team leadership. We are reviewing deals now for WVC7 (Q4\'21+), please reach out if you are raising capital for a scalable venture with traction in a growing market & compelling business model.Co-founder and Portfolio Manager of Greyhound Asset Management, LLC. We achieve our results using a standardized methodology developed in-house and proprietary technology model to construct portfolios of liquid securities, centered in exposure to connected-world technology equities, and functional hedges. Our philosophy marries growth investments with rigorous risk management and fundamental asset screening to deliver favorable risk-adjusted outcomes.Biotechnology BS, Molecular Biology MS, Finance MBA.Strategist, opportunist, relationship builder, focused communicator, and systems thinker with natural and formally trained analytic skills in science, business, and finance.Send me an email at d•••••••@gmail.com to connect directly.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.